<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Infection</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83943EFB-3518-459A-B681-62475A559C89"><gtr:id>83943EFB-3518-459A-B681-62475A559C89</gtr:id><gtr:name>Whitehead Institute for Biomedical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1E84C70A-6153-4CBE-B832-DAB8ED53A5C2"><gtr:id>1E84C70A-6153-4CBE-B832-DAB8ED53A5C2</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Jenner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600081"><gtr:id>40639FEA-71D0-4E2C-8B55-3EC83FDA6BD1</gtr:id><gtr:title>Direct Control of Human Gene Expression by HIV Proteins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0600081</gtr:grantReference><gtr:abstractText>AIDS is one of the most destructive epidemics in human history. HIV, the cause of AIDS, has killed over 25 million people, including 3 million people in 2005 alone. Although anti-viral drugs can slow the disease, there is still no cure or vaccine. HIV, like all viruses, needs to use the cell?s normal machinery to replicate itself. In response, the cell has developed mechanisms that prevent virus replication and trigger an immune response. Recently, it has become clear that HIV takes control of its host cell to create an environment conducive to virus replication and transmission. HIV turns on human genes that help infection and turns off genes that aid the immune response. This may be the Achilles heal of HIV. Preventing HIV from using human genes would block virus replication and, because human genes rarely mutate, this will not lead to HIV resistance. Richard Jenner seeks to use advanced technologies that scan the human genome to discover all the human genes that HIV controls and to learn how HIV controls them. This work, to be carried out at University College London, will identify genes needed by HIV to replicate and provide targets for drugs that will prevent HIV infection.</gtr:abstractText><gtr:technicalSummary>Human immunodeficiency virus type 1 (HIV-1) infection is accompanied by changes in host gene expression that appear to aid virus replication and transmission. The HIV transactivator Tat is able to recapitulate many of these expression changes when expressed alone in cells. The mechanism by which Tat alters human gene expression is not well established. Tat activates HIV gene expression by an unusual mechanism; the protein binds to an RNA stem loop formed in nascent viral transcripts and recruits host transcriptional elongation factors to activate stalled RNA polymerase II. Tat has also been shown to bind to IL6 and SOD2 mRNA, offering the tantalizing possibility that it may act through a similar mechanism to regulate the expression of human genes. Recent work has suggested that Tat is also able to interfere with miRNA-associated gene silencing. 

I hypothesise that HIV Tat localises to human genes to directly regulate transcription. To test this, I will immunoprecipitate epitope-tagged virus proteins from cell lines and HIV-infected cells and identify bound RNA and DNA using custom DNA microarrays containing probes for human mRNAs and promoters. This method, known as location analysis or ChIP-Chip, was pioneered by my current mentor and we have further developed the technique to map protein-nucleic acid interactions at high resolution. I will combine RNA fragmentation and oligo-dT selection with high-resolution mapping to determine whether Tat binds to the 5? end of immature mRNA during transcription. The microarrays will also contain probes for human miRNA sequences to identify any association of Tat with miRNA transcripts. Gene expression analysis of cells expressing Tat mutants will be used together with ChIP-Chip of host transcription factors to determine the mechanism by which Tat regulates the expression of its target genes. The ability of Tat to alter cellular gene expression may have been selected because it aids virus replication. I will therefore also st whether the host factors targeted by Tat promote or inhibit HIV replication and infectivity. HIV encodes two other nucleic acid binding proteins, Vpr and the RNA export factor Rev. Vpr associates with Tat and enhances its ability to activate HIV transcription. I will test whether Vpr and Rev bind to human DNA or RNA and whether Vpr modulates Tat activity at human genes. The interaction of HIV proteins with human RNA during transcription, RNA export or gene silencing would represent new paradigms for virus-host interactions and provide potential host targets for therapeutic intervention.</gtr:technicalSummary><gtr:fund><gtr:end>2012-04-03</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-12-04</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1084018</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Warwick Medical School</gtr:department><gtr:description>Role of polycomb in endometrial stromal sarcoma</gtr:description><gtr:id>09FBE478-8DD9-4D14-A7D4-C875A8E66C9D</gtr:id><gtr:impact>Project grant (&amp;pound;199,000) from the Association for International Cancer Research (AICR).</gtr:impact><gtr:outcomeId>RntzsysQSur-1</gtr:outcomeId><gtr:partnerContribution>Professor Jan Brosens was co-applicant on this proposal and provided some preliminary data.</gtr:partnerContribution><gtr:piContribution>I took the lead in writing a joint grant proposal to the Association for International Cancer Research (AICR), which was funded.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre (CSC)</gtr:department><gtr:description>Polycomb-associated short RNAs</gtr:description><gtr:id>343164F9-35AD-463A-BE09-4067D5D3DBF2</gtr:id><gtr:impact>Publication PMID: 20542000</gtr:impact><gtr:outcomeId>QYH5AioJnge-1</gtr:outcomeId><gtr:partnerContribution>Expertise of ES cell culture and provision of ES cell lines lacking specific proteins.</gtr:partnerContribution><gtr:piContribution>My team designed the study and performed the majority of the research work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Control of T-cell differentiation</gtr:description><gtr:id>064453A9-BB06-4090-AC1A-834DE39A2320</gtr:id><gtr:impact>Publication PMID: 19805038
Wellcome Trust Grant (091009)
Publication PMID: 21876034</gtr:impact><gtr:outcomeId>8C4013300F4-1</gtr:outcomeId><gtr:partnerContribution>Generation of Th1 and Th2 effector T-cells and validation of their phenotypes. Close collaboration in experimental design and analysis and writing up results for publication.</gtr:partnerContribution><gtr:piContribution>Initial study design. Identification of T-bet and GATA-3 binding sites by ChIP-Chip analysis and validation by gene-specific PCR. Analysis of gene expression microarray data. Interpretation of the data in the contect of T-cell differentiation and transcription factor function. Figure generation and writing up study for publication. Writing grant application. Hiring a postdoctoral research associate funded by this new grant. On-going experiments to determine the mechanism through which T-cell genes are regulated.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Whitehead Institute for Biomedical Research</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Polycomb-associated short RNAs (Whitehead)</gtr:description><gtr:id>61375A53-A84A-4CD8-95BF-F329D0A976FE</gtr:id><gtr:impact>Publication PMID: 20542000</gtr:impact><gtr:outcomeId>NeLzeKvKg1m-1</gtr:outcomeId><gtr:partnerContribution>Differentiation of ES cells into motor neurons. Scientific advice and expertise.</gtr:partnerContribution><gtr:piContribution>We conceived the study and performed the vast majority of experiments.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Changes in human gene expression caused by HIV</gtr:description><gtr:id>85C9EA5F-2F02-4721-9F14-1BBA7794E8BD</gtr:id><gtr:impact>17494085</gtr:impact><gtr:outcomeId>C904CB94245-1</gtr:outcomeId><gtr:partnerContribution>Purification of blood cells and their infection with HIV. Experiments to follow up the results of microarray analysis.</gtr:partnerContribution><gtr:piContribution>Analysis and interpretation of microarray results</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Identification of compounds that induce changes in HIV gene expression</gtr:description><gtr:id>F612A9C2-810F-4BC3-BA2F-386D8CC950A8</gtr:id><gtr:impact>Publication. PubMed ID: 20937817
Grant funding of &amp;pound;99,500 from the UCLH/UCL Comprehensive Biomedical Research Centre.
United Kingdom Patent Application No. 1015305.4. Methods, compounds and compositions relating to activating a latent virus. Inventors, Edward Tsao, Richard Jenner and Paul Kellam. Patent held by UCL Business PLC.</gtr:impact><gtr:outcomeId>s2DvFKdNnLq-1</gtr:outcomeId><gtr:piContribution>Idea to test whether compounds identified by our collaborators could reactvite latent HIV. Provision of research materials. Performing experiments. Helping to design research and draft manuscripts and grant applications.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Medicine</gtr:department><gtr:description>Regulatory T-cells in Lupus</gtr:description><gtr:id>5EDCA8D6-6F00-480A-8151-5A476C907FF0</gtr:id><gtr:impact>Grant funding from LupusUK
PhD student enrolled</gtr:impact><gtr:outcomeId>pJ4L3vrPQy6-1</gtr:outcomeId><gtr:partnerContribution>Expertise in auto-immune diseases and access to clinical samples.</gtr:partnerContribution><gtr:piContribution>Co-applicant in a grant application to Lupus UK for consumables to fund our research. Co-supervisor of a PhD student supported by the Oliver Bird Foundation. Study design and technical support.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Soho School visit</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D1289C6C-B0F1-4DDE-A468-5243FBE6A393</gtr:id><gtr:impact>Around 30 primary school children visited the labs, examined blood under the microscope, learnt how to feed cells and constructed their own imagined viruses.

School commented a significant stimulation of the children's interest in science after the visit.</gtr:impact><gtr:outcomeId>Gbash1mkEcC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sixth-form work experience</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DADFAD78-CAEB-4E4F-8379-82C94E10124B</gtr:id><gtr:impact>Hosted sixth form students from a school in a deprived area of London.

A student emailed us to state she was definitely going to apply to study Molecular Biology at university after her visit.</gtr:impact><gtr:outcomeId>HNPhiySEVwH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>50711</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Long-term Fellowship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>F78B6D5F-9564-4EA5-A179-44944A53E5CA</gtr:id><gtr:outcomeId>TAfoV4C22WM0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>199000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:fundingRef>13-0256</gtr:fundingRef><gtr:id>BB4951EB-CB0C-4581-82C0-FF206852AD52</gtr:id><gtr:outcomeId>oPWobwgnwmj</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1499094</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ERC Starting Grant</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:fundingRef>311704</gtr:fundingRef><gtr:id>0D854CF0-6FA4-4010-A7FA-D868E4E9A485</gtr:id><gtr:outcomeId>r5NucpBU7nV</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>237518</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Transcriptional regulation of human T cell differentiation)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A2B671BB-60F0-4C47-AB21-883BCF6456C3</gtr:id><gtr:outcomeId>n7oNgb3GgeR0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>37500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Grant Programme</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>LUPUS UK</gtr:fundingOrg><gtr:id>F62695DD-59E6-4221-828C-72CF690D68F2</gtr:id><gtr:outcomeId>LbcsW2KUDrb0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2418108</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>371033BC-F922-4AF6-9AD3-864E9DD0822A</gtr:id><gtr:outcomeId>WwUdNWSzXRG0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>178000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCLH/UCL Comprehensive Biomedical Research Centre</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0B22AFA4-3594-4851-BCB4-4595B9BAB09F</gtr:id><gtr:outcomeId>09C565CE7A80</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The present inventors have found that anti-microtubule agents can activate a latent virus. Activating a latent virus indicates that the virus is induced into its replicative cycle. Once the latent virus has been activated, an anti-viral agent can act upon the virus. An anti-viral agent includes, but is not limited to an agent that can treat a virus
when it is in its active state, for example when the virus is transcriptionally active in at least one or more cells in a subject.</gtr:description><gtr:grantRef>G0600081</gtr:grantRef><gtr:id>5216E479-CA47-4A15-A283-A995EF6F6641</gtr:id><gtr:impact>None yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>sJfEEzEghag</gtr:outcomeId><gtr:patentId>GB1015305.4</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Compounds to reactivate viruses from latency</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>A compound that is able to reactivate latent virus (retrovirus and herpesvirus) to allow it to be cleared from the body by the immune system in combination with antiviral drugs.</gtr:description><gtr:id>9A6977F2-16EB-407E-AE7A-8345AF65D78B</gtr:id><gtr:impact>New mechanism governing virus latency identified. Paper submitted.</gtr:impact><gtr:outcomeId>KEpriPqiGbq</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>UCLB-15026</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>List of binding sites and genes targeted by the T-cell master regulators T-bet and GATA-3.</gtr:description><gtr:id>E0E65DDC-2123-4CD5-AC30-4CA657069B5B</gtr:id><gtr:impact>None yet.</gtr:impact><gtr:outcomeId>9AD4BDFB8DA</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genomic binding sites of T-bet and GATA-3</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ebi.ac.uk/arrayexpress/experiments/E-TABM-759/</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A list of the genomic coordinates of a novel class of cellular RNAs involved in the regulation of chromatin structure.</gtr:description><gtr:id>531A3DE6-1CB4-4BF5-A46E-8B40438E76F2</gtr:id><gtr:impact>This work has influenced the thoughts of other research groups, as illustrated by its citation in reviews of the fields in high-impact journals such as Science. THe associated paper has been cited 225 times.</gtr:impact><gtr:outcomeId>gGh8GVhPaEo</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Polycomb-associated short RNAs</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.ebi.ac.uk/arrayexpress/experiments/E-TABM-844/</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Dataset identifying the human RNAs that interact with HIV Tat protein.</gtr:description><gtr:id>F8AE0F40-5BAD-42FE-A711-72FDE7729CB7</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>Yhp96Qh744r</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>RNAs bound by HIV Tat</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1ED522EA-F901-4224-8344-8995F998BCD7</gtr:id><gtr:title>Noncoding RNA localisation mechanisms in chromatin regulation.</gtr:title><gtr:parentPublicationTitle>Silence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78ce7ce6c34651c317706ca694dff341"><gtr:id>78ce7ce6c34651c317706ca694dff341</gtr:id><gtr:otherNames>Kanhere A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1758-907X</gtr:issn><gtr:outcomeId>pm_13409_29_22292981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DBEBAD4-B45A-4FBA-B841-BC7F1B081519</gtr:id><gtr:title>Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cd3f637b7203d98d16d16438c247dd"><gtr:id>78cd3f637b7203d98d16d16438c247dd</gtr:id><gtr:otherNames>Ramasubramanyan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13409_29_23015699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>219316D3-4A30-43DD-901A-92513348FA1C</gtr:id><gtr:title>HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b80e4206e65c27027c5eb4c5816ed08"><gtr:id>2b80e4206e65c27027c5eb4c5816ed08</gtr:id><gtr:otherNames>Schaller T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13409_29_22174692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41A506BA-75E4-401E-BA3B-487C3E0E5BC6</gtr:id><gtr:title>Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1884440e1cc5bd5524659b0f3184cc6e"><gtr:id>1884440e1cc5bd5524659b0f3184cc6e</gtr:id><gtr:otherNames>McClellan MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13409_29_22357270</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E7FDF32-3BC6-4E41-B173-CE1E82EA5D19</gtr:id><gtr:title>Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf29f7227bad6014781959a7fbeeeb53"><gtr:id>bf29f7227bad6014781959a7fbeeeb53</gtr:id><gtr:otherNames>Vozzolo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>e9damLsN2J7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAED49AA-5F17-4451-AAA7-D3A4AEF15450</gtr:id><gtr:title>Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78ce7ce6c34651c317706ca694dff341"><gtr:id>78ce7ce6c34651c317706ca694dff341</gtr:id><gtr:otherNames>Kanhere A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>cxNT1hN9nRw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75639FD0-93FF-4E33-B182-3C861925F730</gtr:id><gtr:title>Human immunodeficiency virus Tat associates with a specific set of cellular RNAs.</gtr:title><gtr:parentPublicationTitle>Retrovirology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c33a927cf680d51490b4de1a6aaa092"><gtr:id>6c33a927cf680d51490b4de1a6aaa092</gtr:id><gtr:otherNames>Bouwman RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1742-4690</gtr:issn><gtr:outcomeId>5458fe5e06d2a3.54202904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFAE015B-5B0E-4056-A436-A4F249422456</gtr:id><gtr:title>Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1884440e1cc5bd5524659b0f3184cc6e"><gtr:id>1884440e1cc5bd5524659b0f3184cc6e</gtr:id><gtr:otherNames>McClellan MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5458feb4157826.54204493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83D0773B-5B63-4A28-B65A-30417D15E97F</gtr:id><gtr:title>IL-2 regulates expression of C-MAF in human CD4 T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4bd41f5e795706d066b9db464defb69"><gtr:id>d4bd41f5e795706d066b9db464defb69</gtr:id><gtr:otherNames>Rani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>DEaXubGW9YW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3739CF5B-A369-41D9-BCAB-DFE86C8DED35</gtr:id><gtr:title>Human and simian immunodeficiency virus-mediated upregulation of the apoptotic factor TRAIL occurs in antigen-presenting cells from AIDS-susceptible but not from AIDS-resistant species.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6816bd5656263b2f08a46c9c38d307eb"><gtr:id>6816bd5656263b2f08a46c9c38d307eb</gtr:id><gtr:otherNames>Kim N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>D191C1987E5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D8F9A49-A40F-4148-AC6D-53A3107B2DF3</gtr:id><gtr:title>The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c527f88ccb091966ae1ccaa57f48d497"><gtr:id>c527f88ccb091966ae1ccaa57f48d497</gtr:id><gtr:otherNames>Powell N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_13409_29_23063332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD4F0BF4-7490-49FB-8802-EF2FB52DA81B</gtr:id><gtr:title>The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e953f2388818be25588d7a4cd333da5a"><gtr:id>e953f2388818be25588d7a4cd333da5a</gtr:id><gtr:otherNames>Jenner RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>D79E884C2E4</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600081</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>